Pazonat (Pazopanib) 400 mg
Pazonat 400 (Pazopanib 400 mg) is a tyrosine kinase inhibitor (TKI) used to treat specific types of cancer.
Manufacturer: Natco Pharma (India). A generic equivalent of Votrient.
Mechanism ("Starving the Tumor"):
Pazopanib is an angiogenesis inhibitor. Tumors need a blood supply to grow. This medication stops the formation of new blood vessels that feed the cancer cells. By cutting off the nutrient and oxygen supply, it effectively "starves" the tumor, halting its growth.
✅ Key Benefit: Offers a pill-based treatment option for advanced kidney cancer with proven efficacy.
Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 23.04.2026
What Customers Say
No reviews yet
Your review can be the first!